{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:57:46Z","timestamp":1791874666371,"version":"4.3.4"},"reference-count":215,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"DOI":"10.1038\/s41569-026-01313-8","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:09:21Z","timestamp":1781870961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epigenetic regulation in atherosclerosis and its therapeutic potential"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1811-4746","authenticated-orcid":false,"given":"Donato","family":"Santovito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"Atzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"1313_CR1","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/s41588-022-01233-6","volume":"54","author":"KG Aragam","year":"2022","unstructured":"Aragam, K. G. et al. Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. Nat. Genet. 54, 1803\u20131815 (2022).","journal-title":"Nat. Genet."},{"key":"1313_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal, S. et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N. Engl. J. Med. 377, 111\u2013121 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1313_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/eurheartj\/ehaf602","volume":"47","author":"M von Scheidt","year":"2026","unstructured":"von Scheidt, M. et al. Clonal haematopoiesis of indeterminate potential and mortality in coronary artery disease. Eur. Heart J. 47, 453\u2013469 (2026).","journal-title":"Eur. Heart J."},{"key":"1313_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"355","author":"JJ Fuster","year":"2017","unstructured":"Fuster, J. J. et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 355, 842\u2013847 (2017).","journal-title":"Science"},{"key":"1313_CR5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/150563a0","volume":"150","author":"CH Waddington","year":"1942","unstructured":"Waddington, C. H. Canalization of development and the inheritance of acquired characters. Nature 150, 563\u2013565 (1942).","journal-title":"Nature"},{"key":"1313_CR6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41576-024-00804-z","volume":"26","author":"AK Webster","year":"2025","unstructured":"Webster, A. K. & Phillips, P. C. Epigenetics and individuality: from concepts to causality across timescales. Nat. Rev. Genet. 26, 406\u2013423 (2025).","journal-title":"Nat. Rev. Genet."},{"key":"1313_CR7","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41576-022-00468-7","volume":"23","author":"G Millan-Zambrano","year":"2022","unstructured":"Millan-Zambrano, G., Burton, A., Bannister, A. J. & Schneider, R. Histone post-translational modifications \u2014 cause and consequence of genome function. Nat. Rev. Genet. 23, 563\u2013580 (2022).","journal-title":"Nat. Rev. Genet."},{"key":"1313_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick, J. S. et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat. Rev. Mol. Cell Biol. 24, 430\u2013447 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1313_CR9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","volume":"9","author":"W Dai","year":"2024","unstructured":"Dai, W. et al. Epigenetics-targeted drugs: current paradigms and future challenges. Signal. Transduct. Target. Ther. 9, 332 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1313_CR10","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nrcardio.2015.71","volume":"12","author":"CM Greco","year":"2015","unstructured":"Greco, C. M. & Condorelli, G. Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure. Nat. Rev. Cardiol. 12, 488\u2013497 (2015).","journal-title":"Nat. Rev. Cardiol."},{"key":"1313_CR11","doi-asserted-by":"publisher","first-page":"7118","DOI":"10.1093\/nar\/gkx281","volume":"45","author":"P Zhang","year":"2017","unstructured":"Zhang, P. et al. Methyl-CpG binding domain protein 1 regulates localization and activity of Tet1 in a CXXC3 domain-dependent manner. Nucleic Acids Res. 45, 7118\u20137136 (2017).","journal-title":"Nucleic Acids Res."},{"key":"1313_CR12","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.cell.2018.01.029","volume":"172","author":"SA Lambert","year":"2018","unstructured":"Lambert, S. A. et al. The human transcription factors. Cell 172, 650\u2013665 (2018).","journal-title":"Cell"},{"key":"1313_CR13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41590-025-02113-x","volume":"26","author":"A Jay","year":"2025","unstructured":"Jay, A., Pondevida, C. M. & Vahedi, G. The epigenetic landscape of fate decisions in T cells. Nat. Immunol. 26, 544\u2013556 (2025).","journal-title":"Nat. Immunol."},{"key":"1313_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.molcel.2014.08.024","volume":"56","author":"JD Brown","year":"2014","unstructured":"Brown, J. D. et al. NF-\u03baB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol. Cell 56, 219\u2013231 (2014).","journal-title":"Mol. Cell"},{"key":"1313_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13321-019-0349-4","volume":"11","author":"AJ Sood","year":"2019","unstructured":"Sood, A. J., Viner, C. & Hoffman, M. M. DNAmod: the DNA modification database. J. Cheminform. 11, 30 (2019).","journal-title":"J. Cheminform."},{"key":"1313_CR16","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.tig.2022.03.010","volume":"38","author":"AL Mattei","year":"2022","unstructured":"Mattei, A. L., Bailly, N. & Meissner, A. DNA methylation: a historical perspective. Trends Genet. 38, 676\u2013707 (2022).","journal-title":"Trends Genet."},{"key":"1313_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaj2239","volume":"356","author":"Y Yin","year":"2017","unstructured":"Yin, Y. et al. Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science 356, eaaj2239 (2017).","journal-title":"Science"},{"key":"1313_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41594-024-01241-6","volume":"31","author":"A Monteagudo-Sanchez","year":"2024","unstructured":"Monteagudo-Sanchez, A., Noordermeer, D. & Greenberg, M. V. C. The impact of DNA methylation on CTCF-mediated 3D genome organization. Nat. Struct. Mol. Biol. 31, 404\u2013412 (2024).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1313_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","volume":"99","author":"M Okano","year":"1999","unstructured":"Okano, M., Bell, D. W., Haber, D. A. & Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247\u2013257 (1999).","journal-title":"Cell"},{"key":"1313_CR20","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/embor.2009.218","volume":"10","author":"J Otani","year":"2009","unstructured":"Otani, J. et al. Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX-DNMT3-DNMT3L domain. EMBO Rep. 10, 1235\u20131241 (2009).","journal-title":"EMBO Rep."},{"key":"1313_CR21","doi-asserted-by":"publisher","first-page":"26114","DOI":"10.1074\/jbc.M109.089433","volume":"285","author":"A Dhayalan","year":"2010","unstructured":"Dhayalan, A. et al. The Dnmt3a PWWP domain reads histone 3 lysine 36 trimethylation and guides DNA methylation. J. Biol. Chem. 285, 26114\u201326120 (2010).","journal-title":"J. Biol. Chem."},{"key":"1313_CR22","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.molcel.2017.09.037","volume":"68","author":"S Ishiyama","year":"2017","unstructured":"Ishiyama, S. et al. Structure of the Dnmt1 reader module complexed with a unique two-mono-ubiquitin mark on histone H3 reveals the basis for DNA methylation maintenance. Mol. Cell 68, 350\u2013360.e7 (2017).","journal-title":"Mol. Cell"},{"key":"1313_CR23","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/nsmb.2391","volume":"19","author":"SB Rothbart","year":"2012","unstructured":"Rothbart, S. B. et al. Association of UHRF1 with methylated H3K9 directs the maintenance of DNA methylation. Nat. Struct. Mol. Biol. 19, 1155\u20131160 (2012).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1313_CR24","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","volume":"20","author":"MVC Greenberg","year":"2019","unstructured":"Greenberg, M. V. C. & Bourc\u2019his, D. The diverse roles of DNA methylation in mammalian development and disease. Nat. Rev. Mol. Cell Biol. 20, 590\u2013607 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1313_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","volume":"52","author":"SY Park","year":"2020","unstructured":"Park, S. Y. & Kim, J. S. A short guide to histone deacetylases including recent progress on class II enzymes. Exp. Mol. Med. 52, 204\u2013212 (2020).","journal-title":"Exp. Mol. Med."},{"key":"1313_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41573-024-01080-6","volume":"24","author":"MM Zhou","year":"2025","unstructured":"Zhou, M. M. & Cole, P. A. Targeting lysine acetylation readers and writers. Nat. Rev. Drug Discov. 24, 112\u2013133 (2025).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1313_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev-cancerbio-070120-103531","volume":"6","author":"P Trojer","year":"2022","unstructured":"Trojer, P. Targeting BET bromodomains in cancer. Annu. Rev. Cancer Biol. 6, 313\u2013336 (2022).","journal-title":"Annu. Rev. Cancer Biol."},{"key":"1313_CR28","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1016\/j.molcel.2023.06.032","volume":"83","author":"B Zheng","year":"2023","unstructured":"Zheng, B. et al. Distinct layers of BRD4-PTEFb reveal bromodomain-independent function in transcriptional regulation. Mol. Cell 83, 2896\u20132910.e4 (2023).","journal-title":"Mol. Cell"},{"key":"1313_CR29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41420-023-01775-6","volume":"9","author":"H Qian","year":"2023","unstructured":"Qian, H. et al. Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets. Cell Death Discov. 9, 470 (2023).","journal-title":"Cell Death Discov."},{"key":"1313_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.molcel.2025.12.010","volume":"86","author":"B Zheng","year":"2026","unstructured":"Zheng, B. et al. BRD2 bridges TFIID and MOF-H4K16ac-containing nucleosomes to promote transcriptional initiation. Mol. Cell 86, 273\u2013288 (2026).","journal-title":"Mol. Cell"},{"key":"1313_CR31","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.devcel.2025.09.016","volume":"61","author":"N Wang","year":"2026","unstructured":"Wang, N. et al. A non-canonical immunometabolic function of BRD3 during sepsis. Dev. Cell 61, 322\u2013339.e6 (2026).","journal-title":"Dev. Cell"},{"key":"1313_CR32","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0092-8674(03)00114-4","volume":"112","author":"J Min","year":"2003","unstructured":"Min, J., Feng, Q., Li, Z., Zhang, Y. & Xu, R. M. Structure of the catalytic domain of human DOT1L, a non-SET domain nucleosomal histone methyltransferase. Cell 112, 711\u2013723 (2003).","journal-title":"Cell"},{"key":"1313_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11974","volume":"7","author":"LJ Walport","year":"2016","unstructured":"Walport, L. J. et al. Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases. Nat. Commun. 7, 11974 (2016).","journal-title":"Nat. Commun."},{"key":"1313_CR34","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1126\/science.adc9318","volume":"379","author":"J Lin","year":"2023","unstructured":"Lin, J. et al. Menin \u201creads\u201d H3K79me2 mark in a nucleosomal context. Science 379, 717\u2013723 (2023).","journal-title":"Science"},{"key":"1313_CR35","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","volume":"273","author":"EP Rogakou","year":"1998","unstructured":"Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S. & Bonner, W. M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273, 5858\u20135868 (1998).","journal-title":"J. Biol. Chem."},{"key":"1313_CR36","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.cell.2012.08.005","volume":"150","author":"F Mattiroli","year":"2012","unstructured":"Mattiroli, F. et al. RNF168 ubiquitinates K13-15 on H2A\/H2AX to drive DNA damage signaling. Cell 150, 1182\u20131195 (2012).","journal-title":"Cell"},{"key":"1313_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature12488","volume":"502","author":"A Nishiyama","year":"2013","unstructured":"Nishiyama, A. et al. Uhrf1-dependent H3K23 ubiquitylation couples maintenance DNA methylation and replication. Nature 502, 249\u2013253 (2013).","journal-title":"Nature"},{"key":"1313_CR38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrm.2017.119","volume":"19","author":"RC Allshire","year":"2018","unstructured":"Allshire, R. C. & Madhani, H. D. Ten principles of heterochromatin formation and function. Nat. Rev. Mol. Cell Biol. 19, 229\u2013244 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1313_CR39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nrm.2017.26","volume":"18","author":"CR Clapier","year":"2017","unstructured":"Clapier, C. R., Iwasa, J., Cairns, B. R. & Peterson, C. L. Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes. Nat. Rev. Mol. Cell Biol. 18, 407\u2013422 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1313_CR40","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1073\/pnas.1215379110","volume":"110","author":"HL Schubert","year":"2013","unstructured":"Schubert, H. L. et al. Structure of an actin-related subcomplex of the SWI\/SNF chromatin remodeler. Proc. Natl Acad. Sci. USA 110, 3345\u20133350 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1313_CR41","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S1097-2765(03)00273-9","volume":"12","author":"T Grune","year":"2003","unstructured":"Grune, T. et al. Crystal structure and functional analysis of a nucleosome recognition module of the remodeling factor ISWI. Mol. Cell 12, 449\u2013460 (2003).","journal-title":"Mol. Cell"},{"key":"1313_CR42","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1038\/sj.emboj.7601835","volume":"26","author":"H van Attikum","year":"2007","unstructured":"van Attikum, H., Fritsch, O. & Gasser, S. M. Distinct roles for SWR1 and INO80 chromatin remodeling complexes at chromosomal double-strand breaks. EMBO J. 26, 4113\u20134125 (2007).","journal-title":"EMBO J."},{"key":"1313_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz2294","volume":"12","author":"D Santovito","year":"2020","unstructured":"Santovito, D. et al. Noncanonical inhibition of caspase-3 by a nuclear microRNA confers endothelial protection by autophagy in atherosclerosis. Sci. Transl. Med. 12, eaaz2294 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1313_CR44","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1161\/CIRCULATIONAHA.124.069526","volume":"150","author":"D Santovito","year":"2024","unstructured":"Santovito, D. et al. Mex3a protects against atherosclerosis: evidence from mice and humans. Circulation 150, 1213\u20131216 (2024).","journal-title":"Circulation"},{"key":"1313_CR45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2023.01.009","volume":"374","author":"FM Farina","year":"2023","unstructured":"Farina, F. M., Weber, C. & Santovito, D. The emerging landscape of non-conventional RNA functions in atherosclerosis. Atherosclerosis 374, 74\u201386 (2023).","journal-title":"Atherosclerosis"},{"key":"1313_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003588","volume":"9","author":"LM Holdt","year":"2013","unstructured":"Holdt, L. M. et al. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet. 9, e1003588 (2013).","journal-title":"PLoS Genet."},{"key":"1313_CR47","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0008-6363(99)00153-4","volume":"43","author":"WS Post","year":"1999","unstructured":"Post, W. S. et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc. Res. 43, 985\u2013991 (1999).","journal-title":"Cardiovasc. Res."},{"key":"1313_CR48","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCGENETICS.113.000441","volume":"7","author":"S Zaina","year":"2014","unstructured":"Zaina, S. et al. DNA methylation map of human atherosclerosis. Circ. Cardiovasc. Genet. 7, 692\u2013700 (2014).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"1313_CR49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.atherosclerosis.2018.11.031","volume":"280","author":"M Lacey","year":"2019","unstructured":"Lacey, M., Baribault, C., Ehrlich, K. C. & Ehrlich, M. Atherosclerosis-associated differentially methylated regions can reflect the disease phenotype and are often at enhancers. Atherosclerosis 280, 183\u2013191 (2019).","journal-title":"Atherosclerosis"},{"key":"1313_CR50","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/eurheartj\/ehu437","volume":"36","author":"E Aavik","year":"2015","unstructured":"Aavik, E. et al. Global DNA methylation analysis of human atherosclerotic plaques reveals extensive genomic hypomethylation and reactivation at imprinted locus 14q32 involving induction of a miRNA cluster. Eur. Heart J. 36, 993\u20131000 (2015).","journal-title":"Eur. Heart J."},{"key":"1313_CR51","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1161\/ATVBAHA.115.305630","volume":"35","author":"S Zaina","year":"2015","unstructured":"Zaina, S. et al. DNA methylation dynamics in human carotid plaques after cerebrovascular events. Arterioscler. Thromb. Vasc. Biol. 35, 1835\u20131842 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1313_CR52","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41569-024-01001-5","volume":"21","author":"A Caporali","year":"2024","unstructured":"Caporali, A. et al. Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease. Nat. Rev. Cardiol. 21, 556\u2013573 (2024).","journal-title":"Nat. Rev. Cardiol."},{"key":"1313_CR53","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41569-022-00680-2","volume":"19","author":"D Santovito","year":"2022","unstructured":"Santovito, D. & Weber, C. Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease. Nat. Rev. Cardiol. 19, 620\u2013638 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"1313_CR54","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41569-025-01229-9","volume":"23","author":"T Sallam","year":"2026","unstructured":"Sallam, T., van Solingen, C. & Moore, K. J. Non-coding RNAs in lipid metabolism and their roles in atherosclerosis. Nat. Rev. Cardiol. 23, 324\u2013345 (2026).","journal-title":"Nat. Rev. Cardiol."},{"key":"1313_CR55","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41569-019-0239-5","volume":"17","author":"C Souilhol","year":"2020","unstructured":"Souilhol, C. et al. Endothelial responses to shear stress in atherosclerosis: a novel role for developmental genes. Nat. Rev. Cardiol. 17, 52\u201363 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"1313_CR56","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41569-024-01023-z","volume":"21","author":"Y Doring","year":"2024","unstructured":"Doring, Y., van der Vorst, E. P. C. & Weber, C. Targeting immune cell recruitment in atherosclerosis. Nat. Rev. Cardiol. 21, 824\u2013840 (2024).","journal-title":"Nat. Rev. Cardiol."},{"key":"1313_CR57","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s44161-024-00569-y","volume":"3","author":"A Lin","year":"2024","unstructured":"Lin, A., Miano, J. M., Fisher, E. A. & Misra, A. Chronic inflammation and vascular cell plasticity in atherosclerosis. Nat. Cardiovasc. Res. 3, 1408\u20131423 (2024).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1313_CR58","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1161\/CIRCULATIONAHA.123.067587","volume":"149","author":"H Pan","year":"2024","unstructured":"Pan, H. et al. Atherosclerosis is a smooth muscle cell-driven tumor-like disease. Circulation 149, 1885\u20131898 (2024).","journal-title":"Circulation"},{"key":"1313_CR59","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1172\/JCI74792","volume":"124","author":"J Dunn","year":"2014","unstructured":"Dunn, J. et al. Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis. J. Clin. Invest. 124, 3187\u20133199 (2014).","journal-title":"J. Clin. Invest."},{"key":"1313_CR60","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12195-014-0325-z","volume":"7","author":"J Zhou","year":"2014","unstructured":"Zhou, J., Li, Y. S., Wang, K. C. & Chien, S. Epigenetic mechanism in regulation of endothelial function by disturbed flow: induction of DNA hypermethylation by DNMT1. Cell Mol. Bioeng. 7, 218\u2013224 (2014).","journal-title":"Cell Mol. Bioeng."},{"key":"1313_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-015-1656-4","volume":"16","author":"YZ Jiang","year":"2015","unstructured":"Jiang, Y. Z., Manduchi, E., Stoeckert, C. J. Jr. & Davies, P. F. Arterial endothelial methylome: differential DNA methylation in athero-susceptible disturbed flow regions in vivo. BMC Genomics 16, 506 (2015).","journal-title":"BMC Genomics"},{"key":"1313_CR62","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/CIRCRESAHA.115.303883","volume":"115","author":"YZ Jiang","year":"2014","unstructured":"Jiang, Y. Z. et al. Hemodynamic disturbed flow induces differential DNA methylation of endothelial Kruppel-like factor 4 promoter in vitro and in vivo. Circ. Res. 115, 32\u201343 (2014).","journal-title":"Circ. Res."},{"key":"1313_CR63","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.devcel.2024.12.037","volume":"60","author":"S Gehrs","year":"2025","unstructured":"Gehrs, S. et al. The spatial zonation of the murine placental vasculature is specified by epigenetic mechanisms. Dev. Cell 60, 1467\u20131482.e8 (2025).","journal-title":"Dev. Cell"},{"key":"1313_CR64","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaf435","volume":"53","author":"S Gehrs","year":"2025","unstructured":"Gehrs, S. et al. DNMT3A-dependent DNA methylation shapes the endothelial enhancer landscape. Nucleic Acids Res. 53, gkaf435 (2025).","journal-title":"Nucleic Acids Res."},{"key":"1313_CR65","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.1210\/en.2014-1595","volume":"155","author":"Q Cao","year":"2014","unstructured":"Cao, Q. et al. Inhibiting DNA mMethylation by 5-Aza-2\u2019-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation. Endocrinology 155, 4925\u20134938 (2014).","journal-title":"Endocrinology"},{"key":"1313_CR66","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.7150\/thno.84427","volume":"13","author":"J Zhao","year":"2023","unstructured":"Zhao, J. et al. DNMT1 mediates the disturbed flow-induced endothelial to mesenchymal transition through disrupting \u03b2-alanine and carnosine homeostasis. Theranostics 13, 4392\u20134411 (2023).","journal-title":"Theranostics"},{"key":"1313_CR67","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.molimm.2024.04.001","volume":"170","author":"W Li","year":"2024","unstructured":"Li, W., Bai, P. & Li, W. UHRF1 inhibition mitigates vascular endothelial cell injury and ameliorates atherosclerosis in mice via regulating the SMAD7\/YAP1 axis. Mol. Immunol. 170, 119\u2013130 (2024).","journal-title":"Mol. Immunol."},{"key":"1313_CR68","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1093\/cvr\/cvz027","volume":"115","author":"O Bondareva","year":"2019","unstructured":"Bondareva, O. et al. Identification of atheroprone shear stress responsive regulatory elements in endothelial cells. Cardiovasc. Res. 115, 1487\u20131499 (2019).","journal-title":"Cardiovasc. Res."},{"key":"1313_CR69","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.109.890491","volume":"121","author":"A Zampetaki","year":"2010","unstructured":"Zampetaki, A. et al. Histone deacetylase 3 is critical in endothelial survival and atherosclerosis development in response to disturbed flow. Circulation 121, 132\u2013142 (2010).","journal-title":"Circulation"},{"key":"1313_CR70","doi-asserted-by":"publisher","unstructured":"Chen, L. et al. HDAC3 activates endothelial NLRP3 inflammasome and promotes atherosclerosis via inhibiting the acetylation of specificity protein 1. Cell Death Differ. https:\/\/doi.org\/10.1038\/s41418-025-01620-6 (2025).","DOI":"10.1038\/s41418-025-01620-6"},{"key":"1313_CR71","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1073\/pnas.1121214109","volume":"109","author":"DY Lee","year":"2012","unstructured":"Lee, D. Y. et al. Role of histone deacetylases in transcription factor regulation and cell cycle modulation in endothelial cells in response to disturbed flow. Proc. Natl Acad. Sci. USA 109, 1967\u20131972 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1313_CR72","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10456-015-9485-2","volume":"19","author":"M Maleszewska","year":"2016","unstructured":"Maleszewska, M., Vanchin, B., Harmsen, M. C. & Krenning, G. The decrease in histone methyltransferase EZH2 in response to fluid shear stress alters endothelial gene expression and promotes quiescence. Angiogenesis 19, 9\u201324 (2016).","journal-title":"Angiogenesis"},{"key":"1313_CR73","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.7150\/thno.21966","volume":"8","author":"S Xu","year":"2018","unstructured":"Xu, S. et al. Flow-dependent epigenetic regulation of IGFBP5 expression by H3K27me3 contributes to endothelial anti-inflammatory effects. Theranostics 8, 3007\u20133021 (2018).","journal-title":"Theranostics"},{"key":"1313_CR74","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1111\/jcmm.17135","volume":"26","author":"F Han","year":"2022","unstructured":"Han, F. et al. miR-126-5p enhances radiosensitivity of lung adenocarcinoma cells by inhibiting EZH2 via the KLF2\/BIRC axis. J. Cell Mol. Med. 26, 2529\u20132542 (2022).","journal-title":"J. Cell Mol. Med."},{"key":"1313_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2025.119242","volume":"406","author":"J Fledderus","year":"2025","unstructured":"Fledderus, J. et al. H3K27Me3 abundance is associated with a decreased barrier function of endothelial cells by directly silencing VE-cadherin expression. Atherosclerosis 406, 119242 (2025).","journal-title":"Atherosclerosis"},{"key":"1313_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016282","volume":"6","author":"M Smits","year":"2011","unstructured":"Smits, M. et al. Down-regulation of miR-101 in endothelial cells promotes blood vessel formation through reduced repression of EZH2. PLoS One 6, e16282 (2011).","journal-title":"PLoS One"},{"key":"1313_CR77","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1161\/HYPERTENSIONAHA.112.191098","volume":"60","author":"H Dreger","year":"2012","unstructured":"Dreger, H. et al. Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells. Hypertension 60, 1176\u20131183 (2012).","journal-title":"Hypertension"},{"key":"1313_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102173","volume":"35","author":"H Dunn-Davies","year":"2024","unstructured":"Dunn-Davies, H. et al. Control of endothelial cell function and arteriogenesis by MEG3:EZH2 epigenetic regulation of integrin expression. Mol. Ther. Nucleic Acids 35, 102173 (2024).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1313_CR79","doi-asserted-by":"publisher","first-page":"1373279","DOI":"10.3389\/fcvm.2024.1373279","volume":"11","author":"J Fledderus","year":"2024","unstructured":"Fledderus, J., Brouwer, L., Kuiper, T., Harmsen, M. C. & Krenning, G. H3K27Me3 abundance increases fibrogenesis during endothelial-to-mesenchymal transition via the silencing of microRNA-29c. Front. Cardiovasc. Med. 11, 1373279 (2024).","journal-title":"Front. Cardiovasc. Med."},{"key":"1313_CR80","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3892\/etm.2021.10273","volume":"22","author":"X Wei","year":"2021","unstructured":"Wei, X., Zhang, Y., Xie, L., Wang, K. & Wang, X. Pharmacological inhibition of EZH2 by GSK126 decreases atherosclerosis by modulating foam cell formation and monocyte adhesion in apolipoprotein E-deficient mice. Exp. Ther. Med. 22, 841 (2021).","journal-title":"Exp. Ther. Med."},{"key":"1313_CR81","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1093\/eurheartj\/ehz393","volume":"40","author":"MS Leisegang","year":"2019","unstructured":"Leisegang, M. S. et al. Pleiotropic effects of laminar flow and statins depend on the Kruppel-like factor-induced lncRNA MANTIS. Eur. Heart J. 40, 2523\u20132533 (2019).","journal-title":"Eur. Heart J."},{"key":"1313_CR82","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.116.026991","volume":"136","author":"MS Leisegang","year":"2017","unstructured":"Leisegang, M. S. et al. Long noncoding RNA MANTIS facilitates endothelial angiogenic function. Circulation 136, 65\u201379 (2017).","journal-title":"Circulation"},{"key":"1313_CR83","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1161\/ATVBAHA.113.301765","volume":"33","author":"A Kumar","year":"2013","unstructured":"Kumar, A. et al. Histone and DNA methylation-mediated epigenetic downregulation of endothelial Kruppel-like factor 2 by low-density lipoprotein cholesterol. Arterioscler. Thromb. Vasc. Biol. 33, 1936\u20131942 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1313_CR84","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s44161-025-00622-4","volume":"4","author":"K Li","year":"2025","unstructured":"Li, K. et al. Maternal high-fat diet exacerbates atherosclerosis development in offspring through epigenetic memory. Nat. Cardiovasc. Res. 4, 362\u2013379 (2025).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1313_CR85","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.18632\/aging.100975","volume":"8","author":"S Xu","year":"2016","unstructured":"Xu, S. et al. SIRT6 protects against endothelial dysfunction and atherosclerosis in mice. Aging 8, 1064\u20131082 (2016).","journal-title":"Aging"},{"key":"1313_CR86","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-024-02196-0","volume":"23","author":"J Sanchez-Ceinos","year":"2024","unstructured":"Sanchez-Ceinos, J. et al. Repressive H3K27me3 drives hyperglycemia-induced oxidative and inflammatory transcriptional programs in human endothelium. Cardiovasc. Diabetol. 23, 122 (2024).","journal-title":"Cardiovasc. Diabetol."},{"key":"1313_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05065-z","volume":"9","author":"L Natarelli","year":"2018","unstructured":"Natarelli, L. et al. miR-103 promotes endothelial maladaptation by targeting lncWDR59. Nat. Commun. 9, 2645 (2018).","journal-title":"Nat. Commun."},{"key":"1313_CR88","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw1868","volume":"12","author":"S Haemmig","year":"2020","unstructured":"Haemmig, S. et al. Long noncoding RNA SNHG12 integrates a DNA-PK-mediated DNA damage response and vascular senescence. Sci. Transl. Med. 12, eaaw1868 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1313_CR89","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s44161-024-00474-4","volume":"3","author":"J Lambert","year":"2024","unstructured":"Lambert, J. et al. Network-based prioritization and validation of regulators of vascular smooth muscle cell proliferation in disease. Nat. Cardiovasc. Res. 3, 714\u2013733 (2024).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1313_CR90","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41591-019-0512-5","volume":"25","author":"RC Wirka","year":"2019","unstructured":"Wirka, R. C. et al. Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis. Nat. Med. 25, 1280\u20131289 (2019).","journal-title":"Nat. Med."},{"key":"1313_CR91","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.113.002887","volume":"128","author":"R Liu","year":"2013","unstructured":"Liu, R. et al. Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity. Circulation 128, 2047\u20132057 (2013).","journal-title":"Circulation"},{"key":"1313_CR92","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1172\/JCI26505","volume":"116","author":"OG McDonald","year":"2006","unstructured":"McDonald, O. G., Wamhoff, B. R., Hoofnagle, M. H. & Owens, G. K. Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J. Clin. Invest. 116, 36\u201348 (2006).","journal-title":"J. Clin. Invest."},{"key":"1313_CR93","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1161\/ATVBAHA.125.322645","volume":"45","author":"CH Kong","year":"2025","unstructured":"Kong, C. H. et al. GRK2 orchestrates VSMC phenotypic modulation via DNMT1-mediated DNA methylation reprogramming. Arterioscler. Thromb. Vasc. Biol. 45, 1818\u20131834 (2025).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1313_CR94","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1172\/JCI96121","volume":"128","author":"L Elia","year":"2018","unstructured":"Elia, L. et al. UHRF1 epigenetically orchestrates smooth muscle cell plasticity in arterial disease. J. Clin. Invest. 128, 2473\u20132486 (2018).","journal-title":"J. Clin. Invest."},{"key":"1313_CR95","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jacbts.2018.06.004","volume":"3","author":"W Zhong","year":"2018","unstructured":"Zhong, W. et al. Hypermethylation of the micro-RNA 145 promoter is the key regulator for NLRP3 inflammasome-induced activation and plaque formation. JACC Basic Transl. Sci. 3, 604\u2013624 (2018).","journal-title":"JACC Basic Transl. Sci."},{"key":"1313_CR96","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1161\/CIRCULATIONAHA.121.057599","volume":"145","author":"R Chakraborty","year":"2022","unstructured":"Chakraborty, R. et al. Histone acetyltransferases p300 and CBP coordinate distinct chromatin remodeling programs in vascular smooth muscle plasticity. Circulation 145, 1720\u20131737 (2022).","journal-title":"Circulation"},{"key":"1313_CR97","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/s44161-025-00737-8","volume":"4","author":"JME Tan","year":"2025","unstructured":"Tan, J. M. E. et al. PRDM16 regulates smooth muscle cell identity and atherosclerotic plaque composition. Nat. Cardiovasc. Res. 4, 1573\u20131588 (2025).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1313_CR98","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1161\/CIRCRESAHA.120.318353","volume":"128","author":"MOJ Grootaert","year":"2021","unstructured":"Grootaert, M. O. J., Finigan, A., Figg, N. L., Uryga, A. K. & Bennett, M. R. SIRT6 protects smooth muscle cells from senescence and reduces atherosclerosis. Circ. Res. 128, 474\u201349 (2021).","journal-title":"Circ. Res."},{"key":"1313_CR99","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1093\/eurheartj\/ehac097","volume":"43","author":"FM Farina","year":"2022","unstructured":"Farina, F. M. et al. The epigenetic enzyme DOT1L orchestrates vascular smooth muscle cell-monocyte crosstalk and protects against atherosclerosis via the NF-\u03baB pathway. Eur. Heart J. 43, 4562\u20134576 (2022).","journal-title":"Eur. Heart J."},{"key":"1313_CR100","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2020.06.002","volume":"308","author":"Y Huang","year":"2020","unstructured":"Huang, Y. et al. Nullifying epigenetic writer DOT1L attenuates neointimal hyperplasia. Atherosclerosis 308, 22\u201331 (2020).","journal-title":"Atherosclerosis"},{"key":"1313_CR101","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1161\/ATVBAHA.124.322179","volume":"45","author":"P Chatterjee","year":"2025","unstructured":"Chatterjee, P. et al. SUV39H1 regulates KLF4 and chromatin remodeling in smooth muscle cell phenotypic plasticity. Arterioscler. Thromb. Vasc. Biol. 45, 2015\u20132033 (2025).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1313_CR102","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1161\/ATVBAHA.124.322048","volume":"45","author":"Y Yang","year":"2025","unstructured":"Yang, Y. et al. Suv39h1 regulates phenotypic modulation of smooth muscle cells and contributes to vascular injury by repressing HIC1 transcription. Arterioscler. Thromb. Vasc. Biol. 45, 965\u2013978 (2025).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1313_CR103","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1093\/cvr\/cvad110","volume":"119","author":"N Zhu","year":"2023","unstructured":"Zhu, N. et al. Epigenetic regulation of vascular smooth muscle cell phenotypic switch and neointimal formation by PRMT5. Cardiovasc. Res. 119, 2244\u20132255 (2023).","journal-title":"Cardiovasc. Res."},{"key":"1313_CR104","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1093\/eurheartj\/ehae379","volume":"45","author":"X Li","year":"2024","unstructured":"Li, X. et al. TRAP1 drives smooth muscle cell senescence and promotes atherosclerosis via HDAC3-primed histone H4 lysine 12 lactylation. Eur. Heart J. 45, 4219\u20134235 (2024).","journal-title":"Eur. Heart J."},{"key":"1313_CR105","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1161\/CIRCRESAHA.120.316489","volume":"126","author":"FM Farina","year":"2020","unstructured":"Farina, F. M. et al. miR-128-3p is a novel regulator of vascular smooth muscle cell phenotypic switch and vascular diseases. Circ. Res. 126, e120\u2013e135 (2020).","journal-title":"Circ. Res."},{"key":"1313_CR106","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1161\/CIRCULATIONAHA.123.065202","volume":"150","author":"X Guo","year":"2024","unstructured":"Guo, X. et al. LXR\u03b1 promotes abdominal aortic aneurysm formation through UHRF1 epigenetic modification of miR-26b-3p. Circulation 150, 30\u201346 (2024).","journal-title":"Circulation"},{"key":"1313_CR107","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s44161-023-00337-4","volume":"2","author":"CS Kwartler","year":"2023","unstructured":"Kwartler, C. S. et al. Nuclear smooth muscle \u03b1-actin participates in vascular smooth muscle cell differentiation. Nat. Cardiovasc. Res. 2, 937\u2013955 (2023).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1313_CR108","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","volume":"22","author":"P Roy","year":"2022","unstructured":"Roy, P., Orecchioni, M. & Ley, K. How the immune system shapes atherosclerosis: roles of innate and adaptive immunity. Nat. Rev. Immunol. 22, 251\u2013265 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1313_CR109","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/s41591-024-02953-4","volume":"30","author":"K Pekayvaz","year":"2024","unstructured":"Pekayvaz, K. et al. Multiomic analyses uncover immunological signatures in acute and chronic coronary syndromes. Nat. Med. 30, 1696\u20131710 (2024).","journal-title":"Nat. Med."},{"key":"1313_CR110","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s44161-023-00218-w","volume":"2","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Pairing of single-cell RNA analysis and T cell antigen receptor profiling indicates breakdown of T cell tolerance checkpoints in atherosclerosis. Nat. Cardiovasc. Res. 2, 290\u2013306 (2023).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1313_CR111","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s44161-024-00582-1","volume":"4","author":"T Bleckwehl","year":"2025","unstructured":"Bleckwehl, T. et al. Encompassing view of spatial and single-cell RNA sequencing renews the role of the microvasculature in human atherosclerosis. Nat. Cardiovasc. Res. 4, 26\u201344 (2025).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1313_CR112","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nri3777","volume":"15","author":"D Alvarez-Errico","year":"2015","unstructured":"Alvarez-Errico, D., Vento-Tormo, R., Sieweke, M. & Ballestar, E. Epigenetic control of myeloid cell differentiation, identity and function. Nat. Rev. Immunol. 15, 7\u201317 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1313_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33093-3","volume":"13","author":"MDM Uddin","year":"2022","unstructured":"Uddin, M. D. M. et al. Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease. Nat. Commun. 13, 5350 (2022).","journal-title":"Nat. Commun."},{"key":"1313_CR114","first-page":"805","volume":"2","author":"PJ Rauch","year":"2023","unstructured":"Rauch, P. J. et al. Loss-of-function mutations in Dnmt3a and Tet2 lead to accelerated atherosclerosis and concordant macrophage phenotypes. Nat. Cardiovasc. Res. 2, 805\u2013818 (2023).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1313_CR115","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41577-025-01132-x","volume":"25","author":"G Hajishengallis","year":"2025","unstructured":"Hajishengallis, G., Netea, M. G. & Chavakis, T. Trained immunity in chronic inflammatory diseases and cancer. Nat. Rev. Immunol. 25, 497\u2013514 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"1313_CR116","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","volume":"172","author":"A Christ","year":"2018","unstructured":"Christ, A. et al. Western diet triggers NLRP3-dependent innate immune reprogramming. Cell 172, 162\u2013175.e14 (2018).","journal-title":"Cell"},{"key":"1313_CR117","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ng.1081","volume":"44","author":"International Stroke Genetics Consortium (ISGC).","year":"2012","unstructured":"International Stroke Genetics Consortium (ISGC). Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat. Genet. 44, 328\u2013333 (2012).","journal-title":"Nat. Genet."},{"key":"1313_CR118","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/STROKEAHA.113.002707","volume":"45","author":"M Dichgans","year":"2014","unstructured":"Dichgans, M. et al. Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke 45, 24\u201336 (2014).","journal-title":"Stroke"},{"key":"1313_CR119","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1161\/STROKEAHA.119.026112","volume":"50","author":"M Prestel","year":"2019","unstructured":"Prestel, M. et al. The atherosclerosis risk variant rs2107595 mediates allele-specific transcriptional regulation of HDAC9 via E2F3 and Rb1. Stroke 50, 2651\u20132660 (2019).","journal-title":"Stroke"},{"key":"1313_CR120","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.immuni.2025.01.003","volume":"58","author":"Y Asare","year":"2025","unstructured":"Asare, Y. et al. A cis-regulatory element controls expression of histone deacetylase 9 to fine-tune inflammasome-dependent chronic inflammation in atherosclerosis. Immunity 58, 555\u2013567 e559 (2025).","journal-title":"Immunity"},{"key":"1313_CR121","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1161\/ATVBAHA.114.303393","volume":"34","author":"Q Cao","year":"2014","unstructured":"Cao, Q. et al. Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development. Arterioscler. Thromb. Vasc. Biol. 34, 1871\u20131879 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1313_CR122","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1161\/CIRCRESAHA.120.316743","volume":"127","author":"Y Asare","year":"2020","unstructured":"Asare, Y. et al. Histone deacetylase 9 activates IKK to regulate atherosclerotic plaque vulnerability. Circ. Res. 127, 811\u2013823 (2020).","journal-title":"Circ. Res."},{"key":"1313_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45396-8","volume":"15","author":"X Yu","year":"2024","unstructured":"Yu, X. et al. Structural basis for the oligomerization-facilitated NLRP3 activation. Nat. Commun. 15, 1164 (2024).","journal-title":"Nat. Commun."},{"key":"1313_CR124","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.15252\/emmm.201404170","volume":"6","author":"MA Hoeksema","year":"2014","unstructured":"Hoeksema, M. A. et al. Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions. EMBO Mol. Med. 6, 1124\u20131132 (2014).","journal-title":"EMBO Mol. Med."},{"key":"1313_CR125","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1196704","volume":"14","author":"D Huang","year":"2023","unstructured":"Huang, D. et al. Epigenetically altered macrophages promote development of diabetes-associated atherosclerosis. Front. Immunol. 14, 1196704 (2023).","journal-title":"Front. Immunol."},{"key":"1313_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08344-y","volume":"17","author":"W Wang","year":"2025","unstructured":"Wang, W. et al. HDAC6 deficiency exacerbates atherosclerosis via STAT3-K685 acetylation-mediated CD36\/SR-A upregulation in macrophages. Cell Death Dis. 17, 135 (2025).","journal-title":"Cell Death Dis."},{"key":"1313_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111703","volume":"41","author":"L Willemsen","year":"2022","unstructured":"Willemsen, L. et al. DOT1L regulates lipid biosynthesis and inflammatory responses in macrophages and promotes atherosclerotic plaque stability. Cell Rep. 41, 111703 (2022).","journal-title":"Cell Rep."},{"key":"1313_CR128","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.cell.2007.08.019","volume":"130","author":"F De Santa","year":"2007","unstructured":"De Santa, F. et al. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130, 1083\u20131094 (2007).","journal-title":"Cell"},{"key":"1313_CR129","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nature11262","volume":"488","author":"L Kruidenier","year":"2012","unstructured":"Kruidenier, L. et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 488, 404\u2013408 (2012).","journal-title":"Nature"},{"key":"1313_CR130","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2217\/epi-2016-0152","volume":"9","author":"AE Neele","year":"2017","unstructured":"Neele, A. E. et al. Macrophage Kdm6b controls the pro-fibrotic transcriptome signature of foam cells. Epigenomics 9, 383\u2013391 (2017).","journal-title":"Epigenomics"},{"key":"1313_CR131","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.atherosclerosis.2018.05.052","volume":"275","author":"AE Neele","year":"2018","unstructured":"Neele, A. E. et al. Myeloid Kdm6b deficiency results in advanced atherosclerosis. Atherosclerosis 275, 156\u2013165 (2018).","journal-title":"Atherosclerosis"},{"key":"1313_CR132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157265","volume":"11","author":"YC Lv","year":"2016","unstructured":"Lv, Y. C. et al. Histone methyltransferase enhancer of zeste homolog 2-mediated ABCA1 promoter DNA methylation contributes to the progression of atherosclerosis. PLoS One 11, e0157265 (2016).","journal-title":"PLoS One"},{"key":"1313_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.594603","volume":"11","author":"AE Neele","year":"2020","unstructured":"Neele, A. E. et al. Myeloid Ezh2 deficiency limits atherosclerosis development. Front. Immunol. 11, 594603 (2020).","journal-title":"Front. Immunol."},{"key":"1313_CR134","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1161\/CIRCULATIONAHA.124.072384","volume":"151","author":"CA Bonfiglio","year":"2025","unstructured":"Bonfiglio, C. A. et al. Ezh2 shapes T cell plasticity to drive atherosclerosis. Circulation 151, 1391\u20131408 (2025).","journal-title":"Circulation"},{"key":"1313_CR135","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41586-022-04673-6","volume":"605","author":"SK Mohanta","year":"2022","unstructured":"Mohanta, S. K. et al. Neuroimmune cardiovascular interfaces control atherosclerosis. Nature 605, 152\u2013159 (2022).","journal-title":"Nature"},{"key":"1313_CR136","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/cvr\/cvad016","volume":"119","author":"K van Kuijk","year":"2023","unstructured":"van Kuijk, K. et al. Human and murine fibroblast single-cell transcriptomics reveals fibroblast clusters are differentially affected by ageing and serum cholesterol. Cardiovasc. Res. 119, 1509\u20131523 (2023).","journal-title":"Cardiovasc. Res."},{"key":"1313_CR137","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1038\/s44320-025-00140-2","volume":"21","author":"CS Weldy","year":"2025","unstructured":"Weldy, C. S. et al. Epigenomic landscape of single vascular cells reflects developmental origin and disease risk loci. Mol. Syst. Biol. 21, 1522\u20131546 (2025).","journal-title":"Mol. Syst. Biol."},{"key":"1313_CR138","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3390\/biom13091382","volume":"13","author":"L Chu","year":"2023","unstructured":"Chu, L., Xie, D. & Xu, D. Epigenetic regulation of fibroblasts and crosstalk between cardiomyocytes and non-myocyte cells in cardiac fibrosis. Biomolecules 13, 1382 (2023).","journal-title":"Biomolecules"},{"key":"1313_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12292","volume":"8","author":"M Nayak","year":"2022","unstructured":"Nayak, M. et al. Epigenetic signature in neural plasticity: the journey so far and journey ahead. Heliyon 8, e12292 (2022).","journal-title":"Heliyon"},{"key":"1313_CR140","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adx9221","volume":"11","author":"G Liu","year":"2025","unstructured":"Liu, G. et al. Prdm12 governs an epigenetic checkpoint linking neuroimmune cross-talk to CD8+ T cell exhaustion-suppressed antitumor immunity. Sci. Adv. 11, eadx9221 (2025).","journal-title":"Sci. Adv."},{"key":"1313_CR141","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature08514","volume":"462","author":"R Lister","year":"2009","unstructured":"Lister, R. et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462, 315\u2013322 (2009).","journal-title":"Nature"},{"key":"1313_CR142","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s43587-023-00555-2","volume":"4","author":"PT Griffin","year":"2024","unstructured":"Griffin, P. T. et al. TIME-seq reduces time and cost of DNA methylation measurement for epigenetic clock construction. Nat. Aging 4, 261\u2013274 (2024).","journal-title":"Nat. Aging"},{"key":"1313_CR143","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1161\/CIRCULATIONAHA.124.073181","volume":"152","author":"M Carbonneau","year":"2025","unstructured":"Carbonneau, M. et al. DNA methylation signatures of cardiovascular health provide insights into diseases. Circulation 152, 436\u2013449 (2025).","journal-title":"Circulation"},{"key":"1313_CR144","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-015-0164-3","volume":"7","author":"S Guarrera","year":"2015","unstructured":"Guarrera, S. et al. Gene-specific DNA methylation profiles and LINE-1 hypomethylation are associated with myocardial infarction risk. Clin. Epigenetics 7, 133 (2015).","journal-title":"Clin. Epigenetics"},{"key":"1313_CR145","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41576-024-00807-w","volume":"26","author":"AE Teschendorff","year":"2025","unstructured":"Teschendorff, A. E. & Horvath, S. Epigenetic ageing clocks: statistical methods and emerging computational challenges. Nat. Rev. Genet. 26, 350\u2013368 (2025).","journal-title":"Nat. Rev. Genet."},{"key":"1313_CR146","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015299","volume":"9","author":"K Westerman","year":"2020","unstructured":"Westerman, K. et al. Epigenomic assessment of cardiovascular disease risk and interactions with traditional risk metrics. J. Am. Heart Assoc. 9, e015299 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"1313_CR147","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.123.004265","volume":"17","author":"AD Chybowska","year":"2024","unstructured":"Chybowska, A. D. et al. Epigenetic contributions to clinical risk prediction of cardiovascular disease. Circ. Genom. Precis. Med. 17, e004265 (2024).","journal-title":"Circ. Genom. Precis. Med."},{"key":"1313_CR148","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-022-01341-4","volume":"14","author":"A Cappozzo","year":"2022","unstructured":"Cappozzo, A. et al. A blood DNA methylation biomarker for predicting short-term risk of cardiovascular events. Clin. Epigenetics 14, 121 (2022).","journal-title":"Clin. Epigenetics"},{"key":"1313_CR149","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.117.001937","volume":"11","author":"NS Roetker","year":"2018","unstructured":"Roetker, N. S., Pankow, J. S., Bressler, J., Morrison, A. C. & Boerwinkle, E. Prospective study of epigenetic age acceleration and incidence of cardiovascular disease outcomes in the ARIC study (Atherosclerosis Risk in Communities). Circ. Genom. Precis. Med. 11, e001937 (2018).","journal-title":"Circ. Genom. Precis. Med."},{"key":"1313_CR150","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032743","volume":"13","author":"M Carbonneau","year":"2024","unstructured":"Carbonneau, M. et al. Epigenetic age mediates the association of life\u2019s essential 8 with cardiovascular disease and mortality. J. Am. Heart Assoc. 13, e032743 (2024).","journal-title":"J. Am. Heart Assoc."},{"key":"1313_CR151","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1161\/ATVBAHA.123.320692","volume":"44","author":"E Diez Benavente","year":"2024","unstructured":"Diez Benavente, E. et al. Atherosclerotic plaque epigenetic age acceleration predicts a poor prognosis and is associated with endothelial-to-mesenchymal transition in humans. Arterioscler. Thromb. Vasc. Biol. 44, 1419\u20131431 (2024).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1313_CR152","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1161\/CIRCRESAHA.121.318965","volume":"129","author":"BT Joyce","year":"2021","unstructured":"Joyce, B. T. et al. Epigenetic age acceleration reflects long-term cardiovascular health. Circ. Res. 129, 770\u2013781 (2021).","journal-title":"Circ. Res."},{"key":"1313_CR153","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s43587-025-00883-5","volume":"5","author":"M Fuentealba","year":"2025","unstructured":"Fuentealba, M. et al. A blood-based epigenetic clock for intrinsic capacity predicts mortality and is associated with clinical, immunological and lifestyle factors. Nat. Aging 5, 1207\u20131216 (2025).","journal-title":"Nat. Aging"},{"key":"1313_CR154","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/jamacardio.2021.2704","volume":"6","author":"A Navas-Acien","year":"2021","unstructured":"Navas-Acien, A. et al. Blood DNA methylation and incident coronary heart disease: evidence from the strong heart study. JAMA Cardiol. 6, 1237\u20131246 (2021).","journal-title":"JAMA Cardiol."},{"key":"1313_CR155","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1038\/s41467-026-70216-6","volume":"17","author":"D Hecker","year":"2026","unstructured":"Hecker, D. et al. Cell type-specific epigenetic regulatory circuitry of coronary artery disease loci. Nat. Commun. 17, 2367 (2026).","journal-title":"Nat. Commun."},{"key":"1313_CR156","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"EP Consortium","year":"2012","unstructured":"Consortium, E. P. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57\u201374 (2012).","journal-title":"Nature"},{"key":"1313_CR157","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/nbt1010-1045","volume":"28","author":"BE Bernstein","year":"2010","unstructured":"Bernstein, B. E. et al. The NIH roadmap epigenomics mapping consortium. Nat. Biotechnol. 28, 1045\u20131048 (2010).","journal-title":"Nat. Biotechnol."},{"key":"1313_CR158","doi-asserted-by":"publisher","first-page":"E11349","DOI":"10.1073\/pnas.1810568115","volume":"115","author":"MD Krause","year":"2018","unstructured":"Krause, M. D. et al. Genetic variant at coronary artery disease and ischemic stroke locus 1p32.2 regulates endothelial responses to hemodynamics. Proc. Natl Acad. Sci. USA 115, E11349\u2013E11358 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1313_CR159","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/CIRCRESAHA.117.306457","volume":"117","author":"C Wu","year":"2015","unstructured":"Wu, C. et al. Mechanosensitive PPAP2B regulates endothelial responses to atherorelevant hemodynamic forces. Circ. Res. 117, e41\u2013e53 (2015).","journal-title":"Circ. Res."},{"key":"1313_CR160","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1161\/ATVBAHA.123.318964","volume":"44","author":"I Selvarajan","year":"2024","unstructured":"Selvarajan, I. et al. Coronary artery disease risk variant dampens the expression of CALCRL by reducing hsf binding to shear stress responsive enhancer in endothelial cells in vitro. Arterioscler. Thromb. Vasc. Biol. 44, 1330\u20131345 (2024).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1313_CR161","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/s44161-025-00714-1","volume":"4","author":"N Barbera","year":"2025","unstructured":"Barbera, N. et al. Coronary artery disease-associated variants regulate vascular smooth muscle cell gene expression. Nat. Cardiovasc. Res. 4, 1295\u20131310 (2025).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1313_CR162","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/CIRCRESAHA.121.318971","volume":"129","author":"T Ord","year":"2021","unstructured":"Ord, T. et al. Single-cell epigenomics and functional fine-mapping of atherosclerosis GWAS Loci. Circ. Res. 129, 240\u2013258 (2021).","journal-title":"Circ. Res."},{"key":"1313_CR163","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41588-022-01069-0","volume":"54","author":"AW Turner","year":"2022","unstructured":"Turner, A. W. et al. Single-nucleus chromatin accessibility profiling highlights regulatory mechanisms of coronary artery disease risk. Nat. Genet. 54, 804\u2013816 (2022).","journal-title":"Nat. Genet."},{"key":"1313_CR164","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.117.027646","volume":"136","author":"Y Doring","year":"2017","unstructured":"Doring, Y. et al. Vascular CXCR4 limits atherosclerosis by maintaining arterial integrity: evidence from mouse and human studies. Circulation 136, 388\u2013403 (2017).","journal-title":"Circulation"},{"key":"1313_CR165","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1161\/ATVBAHA.121.315579","volume":"41","author":"PR Moreau","year":"2021","unstructured":"Moreau, P. R. et al. Profiling of primary and mature miRNA expression in atherosclerosis-associated cell types. Arterioscler. Thromb. Vasc. Biol. 41, 2149\u20132167 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1313_CR166","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf3357","volume":"15","author":"I Cimen","year":"2023","unstructured":"Cimen, I. et al. Targeting a cell-specific microRNA repressor of CXCR4 ameliorates atherosclerosis in mice. Sci. Transl. Med. 15, eadf3357 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1313_CR167","doi-asserted-by":"publisher","DOI":"10.1186\/1868-7083-6-14","volume":"6","author":"SP Guay","year":"2014","unstructured":"Guay, S. P. et al. Acetylsalicylic acid, aging and coronary artery disease are associated with ABCA1 DNA methylation in men. Clin. Epigenetics 6, 14 (2014).","journal-title":"Clin. Epigenetics"},{"key":"1313_CR168","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/17425255.2025.2491732","volume":"21","author":"C Kayzuka","year":"2025","unstructured":"Kayzuka, C. et al. Epigenetics is involved in the pleiotropic effects of statins. Expert Opin. Drug Metab. Toxicol. 21, 689\u2013701 (2025).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"1313_CR169","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2014.06.008","volume":"236","author":"R Jahagirdar","year":"2014","unstructured":"Jahagirdar, R. et al. A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice. Atherosclerosis 236, 91\u2013100 (2014).","journal-title":"Atherosclerosis"},{"key":"1313_CR170","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1016\/j.jacc.2010.02.035","volume":"55","author":"D Bailey","year":"2010","unstructured":"Bailey, D. et al. RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo. J. Am. Coll. Cardiol. 55, 2580\u20132589 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1313_CR171","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40256-015-0146-z","volume":"16","author":"SJ Nicholls","year":"2016","unstructured":"Nicholls, S. J. et al. Effect of the BET protein inhibitor, RVX-208, on progression of coronary atherosclerosis: results of the phase 2b, randomized, double-blind, multicenter, ASSURE trial. Am. J. Cardiovasc. Drugs 16, 55\u201365 (2016).","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"1313_CR172","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0696-z","volume":"11","author":"LM Tsujikawa","year":"2019","unstructured":"Tsujikawa, L. M. et al. Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism. Clin. Epigenetics 11, 102 (2019).","journal-title":"Clin. Epigenetics"},{"key":"1313_CR173","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40256-017-0250-3","volume":"18","author":"SJ Nicholls","year":"2018","unstructured":"Nicholls, S. J. et al. Selective BET protein inhibition with apabetalone and cardiovascular events: a pooled analysis of trials in patients with coronary artery disease. Am. J. Cardiovasc. Drugs 18, 109\u2013115 (2018).","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"1313_CR174","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1001\/jama.2020.3308","volume":"323","author":"KK Ray","year":"2020","unstructured":"Ray, K. K. et al. Effect of apabetalone added to standard therapy on major adverse cardiovascular events in patients with recent acute coronary syndrome and type 2 diabetes: a randomized clinical trial. JAMA 323, 1565\u20131573 (2020).","journal-title":"JAMA"},{"key":"1313_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2022.100372","volume":"11","author":"PP Toth","year":"2022","unstructured":"Toth, P. P. et al. Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and moderate to high likelihood of non-alcoholic fatty liver disease. Am. J. Prev. Cardiol. 11, 100372 (2022).","journal-title":"Am. J. Prev. Cardiol."},{"key":"1313_CR176","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"PM Ridker","year":"2008","unstructured":"Ridker, P. M. et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359, 2195\u20132207 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1313_CR177","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1313_CR178","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif, J. C. et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N. Engl. J. Med. 381, 2497\u20132505 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1313_CR179","doi-asserted-by":"publisher","first-page":"6042","DOI":"10.1039\/C9FO01075K","volume":"10","author":"A Hoseini","year":"2019","unstructured":"Hoseini, A. et al. The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease. Food Funct. 10, 6042\u20136051 (2019).","journal-title":"Food Funct."},{"key":"1313_CR180","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55923-8","volume":"14","author":"N Chang","year":"2024","unstructured":"Chang, N. et al. Emerging roles of SIRT1 activator, SRT2104, in disease treatment. Sci. Rep. 14, 5521 (2024).","journal-title":"Sci. Rep."},{"key":"1313_CR181","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41586-024-07087-8","volume":"627","author":"MA Cappelluti","year":"2024","unstructured":"Cappelluti, M. A. et al. Durable and efficient gene silencing in vivo by hit-and-run epigenome editing. Nature 627, 416\u2013423 (2024).","journal-title":"Nature"},{"key":"1313_CR182","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/01.ATV.0000184758.07257.88","volume":"25","author":"JH Choi","year":"2005","unstructured":"Choi, J. H. et al. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 25, 2404\u20132409 (2005).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1313_CR183","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41580-021-00438-7","volume":"23","author":"A Loda","year":"2022","unstructured":"Loda, A., Collombet, S. & Heard, E. Gene regulation in time and space during X-chromosome inactivation. Nat. Rev. Mol. Cell Biol. 23, 231\u2013249 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1313_CR184","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41586-025-08656-1","volume":"640","author":"M Liu","year":"2025","unstructured":"Liu, M. et al. Genome-coverage single-cell histone modifications for embryo lineage tracing. Nature 640, 828\u2013839 (2025).","journal-title":"Nature"},{"key":"1313_CR185","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1016\/j.cell.2025.05.011","volume":"188","author":"M Yagi","year":"2025","unstructured":"Yagi, M. et al. Bivalent chromatin instructs lineage specification during hematopoiesis. Cell 188, 4314\u20134331.e29 (2025).","journal-title":"Cell"},{"key":"1313_CR186","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cell.2012.09.044","volume":"151","author":"G Vahedi","year":"2012","unstructured":"Vahedi, G. et al. STATs shape the active enhancer landscape of T cell populations. Cell 151, 981\u2013993 (2012).","journal-title":"Cell"},{"key":"1313_CR187","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41580-025-00828-1","volume":"26","author":"I Chiolo","year":"2025","unstructured":"Chiolo, I., Altmeyer, M., Legube, G. & Mekhail, K. Nuclear and genome dynamics underlying DNA double-strand break repair. Nat. Rev. Mol. Cell Biol. 26, 538\u2013557 (2025).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1313_CR188","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1016\/j.molcel.2024.07.030","volume":"84","author":"S Tamburri","year":"2024","unstructured":"Tamburri, S., Rustichelli, S., Amato, S. & Pasini, D. Navigating the complexity of polycomb repression: enzymatic cores and regulatory modules. Mol. Cell 84, 3381\u20133405 (2024).","journal-title":"Mol. Cell"},{"key":"1313_CR189","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.molcel.2018.03.019","volume":"70","author":"CH Lee","year":"2018","unstructured":"Lee, C. H. et al. Distinct stimulatory mechanisms regulate the catalytic activity of polycomb repressive complex 2. Mol. Cell 70, 435\u2013448.e5 (2018).","journal-title":"Mol. Cell"},{"key":"1313_CR190","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.molcel.2018.01.039","volume":"69","author":"S Chen","year":"2018","unstructured":"Chen, S., Jiao, L., Shubbar, M., Yang, X. & Liu, X. Unique structural platforms of suz12 dictate distinct classes of PRC2 for chromatin binding. Mol. Cell 69, 840\u2013852.e5 (2018).","journal-title":"Mol. Cell"},{"key":"1313_CR191","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.molcel.2020.11.044","volume":"81","author":"DT Youmans","year":"2021","unstructured":"Youmans, D. T., Gooding, A. R., Dowell, R. D. & Cech, T. R. Competition between PRC2.1 and 2.2 subcomplexes regulates PRC2 chromatin occupancy in human stem cells. Mol. Cell 81, 488\u2013501.e9 (2021).","journal-title":"Mol. Cell"},{"key":"1313_CR192","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1016\/j.molcel.2025.07.014","volume":"85","author":"C Much","year":"2025","unstructured":"Much, C. et al. Distinct specificity and functions of PRC2 subcomplexes in human stem cells and cardiac differentiation. Mol. Cell 85, 3057\u20133073.e10 (2025).","journal-title":"Mol. Cell"},{"key":"1313_CR193","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.tibs.2025.11.003","volume":"51","author":"MY Bhat","year":"2026","unstructured":"Bhat, M. Y. & Liu, X. Emerging structural insights into PRC2 function in development and disease. Trends Biochem. Sci. 51, 172\u2013186 (2026).","journal-title":"Trends Biochem. Sci."},{"key":"1313_CR194","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20940-y","volume":"12","author":"Y Cai","year":"2021","unstructured":"Cai, Y. et al. H3K27me3-rich genomic regions can function as silencers to repress gene expression via chromatin interactions. Nat. Commun. 12, 719 (2021).","journal-title":"Nat. Commun."},{"key":"1313_CR195","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1038\/sj.emboj.7600402","volume":"23","author":"D Pasini","year":"2004","unstructured":"Pasini, D., Bracken, A. P., Jensen, M. R., Lazzerini Denchi, E. & Helin, K. Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J. 23, 4061\u20134071 (2004).","journal-title":"EMBO J."},{"key":"1313_CR196","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.1128\/MCB.21.13.4330-4336.2001","volume":"21","author":"D O\u2019Carroll","year":"2001","unstructured":"O\u2019Carroll, D. et al. The polycomb-group gene Ezh2 is required for early mouse development. Mol. Cell Biol. 21, 4330\u20134336 (2001).","journal-title":"Mol. Cell Biol."},{"key":"1313_CR197","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/383250a0","volume":"383","author":"A Shumacher","year":"1996","unstructured":"Shumacher, A., Faust, C. & Magnuson, T. Positional cloning of a global regulator of anterior-posterior patterning in mice. Nature 383, 250\u2013253 (1996).","journal-title":"Nature"},{"key":"1313_CR198","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.stem.2013.10.001","volume":"14","author":"H Xie","year":"2014","unstructured":"Xie, H. et al. Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner. Cell Stem Cell 14, 68\u201380 (2014).","journal-title":"Cell Stem Cell"},{"key":"1313_CR199","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/nn.4360","volume":"19","author":"M von Schimmelmann","year":"2016","unstructured":"von Schimmelmann, M. et al. Polycomb repressive complex 2 (PRC2) silences genes responsible for neurodegeneration. Nat. Neurosci. 19, 1321\u20131330 (2016).","journal-title":"Nat. Neurosci."},{"key":"1313_CR200","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s43586-020-00008-9","volume":"1","author":"L Minnoye","year":"2021","unstructured":"Minnoye, L. et al. Chromatin accessibility profiling methods. Nat. Rev. Methods Primers 1, 10 (2021).","journal-title":"Nat. Rev. Methods Primers"},{"key":"1313_CR201","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/nature15740","volume":"528","author":"W Jin","year":"2015","unstructured":"Jin, W. et al. Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples. Nature 528, 142\u2013146 (2015).","journal-title":"Nature"},{"key":"1313_CR202","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nature14590","volume":"523","author":"JD Buenrostro","year":"2015","unstructured":"Buenrostro, J. D. et al. Single-cell chromatin accessibility reveals principles of regulatory variation. Nature 523, 486\u2013490 (2015).","journal-title":"Nature"},{"key":"1313_CR203","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.cell.2020.09.056","volume":"183","author":"S Ma","year":"2020","unstructured":"Ma, S. et al. Chromatin potential identified by shared single-cell profiling of RNA and chromatin. Cell 183, 1103\u20131116.e20 (2020).","journal-title":"Cell"},{"key":"1313_CR204","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1016\/j.cell.2025.03.037","volume":"188","author":"MT Nikolova","year":"2025","unstructured":"Nikolova, M. T. et al. Fate and state transitions during human blood vessel organoid development. Cell 188, 3329\u20133348.e31 (2025).","journal-title":"Cell"},{"key":"1313_CR205","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1038\/s41596-025-01145-9","volume":"20","author":"H Li","year":"2025","unstructured":"Li, H. et al. Spatially resolved genome-wide joint profiling of epigenome and transcriptome with spatial-ATAC-RNA-seq and spatial-CUT&Tag-RNA-seq. Nat. Protoc. 20, 2383\u20132417 (2025).","journal-title":"Nat. Protoc."},{"key":"1313_CR206","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s11658-021-00290-9","volume":"26","author":"R Halabian","year":"2021","unstructured":"Halabian, R. et al. Laboratory methods to decipher epigenetic signatures: a comparative review. Cell Mol. Biol. Lett. 26, 46 (2021).","journal-title":"Cell Mol. Biol. Lett."},{"key":"1313_CR207","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/s41592-019-0547-z","volume":"16","author":"DS Lee","year":"2019","unstructured":"Lee, D. S. et al. Simultaneous profiling of 3D genome structure and DNA methylation in single human cells. Nat. Methods 16, 999\u20131006 (2019).","journal-title":"Nat. Methods"},{"key":"1313_CR208","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/s41586-025-09478-x","volume":"646","author":"CN Lee","year":"2025","unstructured":"Lee, C. N., Fu, H., Cardilla, A., Zhou, W. & Deng, Y. Spatial joint profiling of DNA methylome and transcriptome in tissues. Nature 646, 1261\u20131271 (2025).","journal-title":"Nature"},{"key":"1313_CR209","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2007.05.009","volume":"129","author":"A Barski","year":"2007","unstructured":"Barski, A. et al. High-resolution profiling of histone methylations in the human genome. Cell 129, 823\u2013837 (2007).","journal-title":"Cell"},{"key":"1313_CR210","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.21856","volume":"6","author":"PJ Skene","year":"2017","unstructured":"Skene, P. J. & Henikoff, S. An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. eLife 6, e21856 (2017).","journal-title":"eLife"},{"key":"1313_CR211","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09982-5","volume":"10","author":"HS Kaya-Okur","year":"2019","unstructured":"Kaya-Okur, H. S. et al. CUT&Tag for efficient epigenomic profiling of small samples and single cells. Nat. Commun. 10, 1930 (2019).","journal-title":"Nat. Commun."},{"key":"1313_CR212","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11559-1","volume":"10","author":"B Carter","year":"2019","unstructured":"Carter, B. et al. Mapping histone modifications in low cell number and single cells using antibody-guided chromatin tagmentation (ACT-seq). Nat. Commun. 10, 3747 (2019).","journal-title":"Nat. Commun."},{"key":"1313_CR213","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41587-021-00869-9","volume":"39","author":"M Bartosovic","year":"2021","unstructured":"Bartosovic, M., Kabbe, M. & Castelo-Branco, G. Single-cell CUT&Tag profiles histone modifications and transcription factors in complex tissues. Nat. Biotechnol. 39, 825\u2013835 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1313_CR214","doi-asserted-by":"publisher","unstructured":"Chen, Y. et al. Gene regulatory landscape dissected by single-cell four-omics sequencing. Nature https:\/\/doi.org\/10.1038\/s41586-026-10322-z (2026).","DOI":"10.1038\/s41586-026-10322-z"},{"key":"1313_CR215","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41576-023-00586-w","volume":"24","author":"L Heumos","year":"2023","unstructured":"Heumos, L. et al. Best practices for single-cell analysis across modalities. Nat. Rev. Genet. 24, 550\u2013572 (2023).","journal-title":"Nat. Rev. Genet."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01313-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01313-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01313-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:04:29Z","timestamp":1781874269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01313-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":215,"alternative-id":["1313"],"URL":"https:\/\/doi.org\/10.1038\/s41569-026-01313-8","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"1 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}